Nitrergic-purinergic interactions in rat distal colon motility

Neurogastroenterology and Motility

Volumn 16, Issue 1, 2004, Pages 81-98

  Van Crombruggen, K ^a   Lefebvre, R A ^a  

^a GHENT UNIVERSITY   (Belgium)

Author keywords

Colonic motility (distal); Nitrergic purinergic; Non adrenergic; Non cholinergic; Rat (Wistar); Small conductance Ca2+ dependant K+ channels; Smooth muscle relaxation

Indexed keywords

1H 1,2,4 OXADIAZOLO[4,3 A]QUINOXALIN 1 ONE; ADENOSINE TRIPHOSPHATE; APAMIN; CALCIUM ION; CIBACRON BLUE F3GA; GUANYLATE CYCLASE INHIBITOR; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; POTASSIUM ION; PURINE RECEPTOR; TETRODOTOXIN;

ANIMAL TISSUE; ARTICLE; COLON MOTILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DESCENDING COLON; ELECTRIC FIELD; MALE; MOLECULAR INTERACTION; NEUROTRANSMISSION; NITRERGIC NERVE; NONHUMAN; PRIORITY JOURNAL; RAT; SMOOTH MUSCLE RELAXATION;

ADENOSINE TRIPHOSPHATE; ANIMALS; APAMIN; COLON; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTRIC STIMULATION; ENDOTHELIUM-DEPENDENT RELAXING FACTORS; ENZYME INHIBITORS; MALE; MUSCLE RELAXATION; MUSCLE, SMOOTH; NITRIC OXIDE; ORGAN CULTURE TECHNIQUES; POTASSIUM CHANNELS, CALCIUM-ACTIVATED; PURINES; RATS; SIGNAL TRANSDUCTION;

EID: 1342267701     PISSN: 13501925     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2982.2003.00454.x     Document Type: Article

References (57)

1. Rand MJ, Li CG. Nitric oxide as a neurotransmitter in peripheral nerves: nature of transmitter and mechanism of transmission. Annu Rev Physiol 1995; 57: 659-82.
2. Stark ME, Szurszewski JH. Role of nitric oxide in gastrointestinal and hepatic function and disease. Gastroenterology 1992; 103: 1928-49.
3. Burnstock G. Overview. Purinergic mechanisms. Ann N Y Acad Sci 1990; 603: 1-17.
4. Takahashi O. Regional differences in the nitrergic innervation between the proximal and the distal colon in rats. Gastroenterology 1998; 115: 1504-12.
5. Börjesson L, Nordgren S, Delbro DS. DMPP causes relaxation of rat distal colon by a purinergic and a nitrergic mechanism. Eur J Pharmacol 1997; 334: 223-31.
6. Börjesson L, Nordgren S, Delbro DS. K(+)-induced neurogenic relaxation of rat distal colon. J Pharmacol Exp Ther 1999; 291: 717-24.
7. Qian YM, Jones RL. Inhibition of rat colon contractility by prostacyclin (IP-) receptor agonists: involvement of NANC neurotransmission. Br J Pharmacol 1995; 115: 163-71.
8. Suthamnatpong N, Hata F, Kanada A, Takeuchi T, Yagasaki O. Mediators of nonadrenergic, noncholinergic inhibition in the proximal, middle and distal regions of rat colon. Br J Pharmacol 1993; 108: 348-55.
9. Maehara T, Fujita A, Suthamnatpong N, Takeuchi T, Hata F. Differences in relaxant effects of cyclic GMP on skinned muscle preparations from the proximal and distal colon of rats. Eur J Pharmacol 1994; 261: 163-70.
10. Okishio Y, Niioka S, Takeuchi T, Nishio H, Hata F, Takatsuji K. Differences in mediator of nonadrenergic, noncholinergic relaxation of the distal colon between Wistar-ST and Sprague-Dawley strains of rats. Eur J Pharmacol 2000; 388: 97-105.
11. Niklasson LG, Fasth S, Hulten L, Delbro DS. Inhibition of nitric oxide synthase causes excitation of the circular muscle in rat distal colon. Acta Physiol Scand 1992; 144: 489-90.
12. Middleton SJ, Cuthbert AW, Shorthouse M, Hunter JO. Nitric oxide affects mammalian distal colonic smooth muscle by tonic neural inhibition. Br J Pharmacol 1993; 108: 974-9.
13. Bailey SJ, Hourani SM. Effects of purines on the longitudinal muscle of the rat colon. Br J Pharmacol 1992; 105: 885-92.
14. Belai A, Burnstock G. Evidence for coexistence of ATP and nitric oxide in non-adrenergic, non-cholinergic (NANC) inhibitory neurones in the rat ileum, colon and anococcygeus muscle. Cell Tissue Res 1994; 278: 197-200.
15. + channels. Br J Pharmacol 1999; 127: 514-20.
16. Hofmann F, Ammendola A, Schlossmann J. Rising behind NO: cGMP-dependent protein kinases. J Cell Sci 2000; 113: 1671-6 (Review).
17. Lucas KA, Pitari GM, Kazerounian S et al. Guanylyl cyclases and signaling by cyclic GMP. Pharmacol Rev 2000; 52: 375-414 (Review).
18. Esplugues JV. NO as a signalling molecule in the nervous system. Br J Pharmacol 2002; 135: 1079-95 (Review).
19. Kelm M, Schrader J. Control of coronary vascular tone by nitric oxide. Circ Res 1990; 66: 1561-75.
20. Serio R, Mule F, Postorino A. Nonadrenergic, noncholinergic inhibitory junction potentials in rat proximal colon: role of nitric oxide. Can J Physiol Pharmacol 1995; 73: 79-84.
21. Christinck F, Jury J, Cayabyab F, Daniel EE. Nitric oxide may be the final mediator of nonadrenergic, noncholinergic inhibitory junction potentials in the gut. Can J Physiol Pharmacol 1991; 69: 1448-58.
22. Koh SD, Campbell JD, Carl A, Sanders KM. Nitric oxide activates multiple channels in canine colonic smooth muscle. J Physiol 1995; 489: 735-43.
23. Selemidis S, Satchell DG, Cocks TM. Evidence that NO acts as a redundant NANC inhibitory neurotransmitter in the guinea-pig isolated taenia coli. Br J Pharmacol 1997; 121: 604-11.
24. Watson MJ, Bywater RA, Taylor GS, Lang RJ. Effects of nitric oxide (NO) and NO donors on the membrane conductance of circular smooth muscle cells of the guinea-pig proximal colon. Br J Pharmacol 1996; 118: 1605-14.
25. Bolotina VM, Najibi S, Palacino JJ, Pagano PJ, Cohen RA. Nitric oxide directly activates calcium-dependent potassium channels in vascular smooth muscle. Nature 1994; 368: 850-5.
26. Martins SLR, De Oliveira RB, Ballejo G. Rat duodenum nitrergic-induced relaxations are cGMP-independent and apamin-sensitive. Eur J Pharmacol 1995; 284: 265-70.
27. Shuttleworth CWR, Sweeney KM, Sanders KM. Evidence that nitric oxide acts as an inhibitory neurotransmitter supplying taenia from the guinea-pig caecum. Br J Pharmacol 1999; 127: 1495-501.
28. Matsuyama H, Thapaliya S, Takewaki T. Cyclic GMP-associated apamin-sensitive nitrergic slow inhibitory junction potential in the hamster ileum. Br J Pharmacol 1999; 128: 830-6.
29. Suthamnatpong N, Hosokawa M, Takeuchi T, Hata F, Takewaki T. Nitric oxide-mediated inhibitory response of rat proximal colon: independence of changes in membrane potential. Br J Pharmacol 1994; 112: 676-82.
30. Takeuchi T, Kishi M, Ishii T, Nishio H, Hata F. Nitric oxide-mediated relaxation without concomitant changes is cyclic GMP content of rat proximal colon. Br J Pharmacol 1996; 117: 1204-8.
31. Fujita A, Takeuchi T, Saitoh N, Hanai J, Hata F. Expression of Ca(2+)-activated K(+) channels, SK3, in the interstitial cells of Cajal in the gastrointestinal tract. Am J Physiol Cell Physiol 2001; 281: C1727-33.
32. Kohler M, Hirschberg B, Bond CT et al. Small-conductance, calcium-activated potassium channels from mammalian brain. Science 1996; 273: 1709-14.
33. Ishii TM, Maylie J, Adelman JP. Determinants of apamin and D-tubocurarine block in SK potassium channels. J Biol Chem 1997; 272: 23195-200.
34. Vergara C, Latorre R, Marrion NV, Adelman JP. Calcium-activated potassium channels. Review. Curr Opin Neurobiol 1998; 8: 321-9 (Review).
35. Grunnet M, Jensen BS, Olesen SP, Klaerke DA. Apamin interacts with all subtypes of cloned small-conductance Ca2+-activated K+ channels. Pflugers Arch 2001; 441: 544-50.
36. Shah M, Haylett DG. The pharmacology of hSK1 Ca2+-activated K+ channels expressed in mammalian cell lines. Br J Pharmacol 2000; 129: 627-30.
37. Bultmann R, Dudeck O, Starke K. Evaluation of P2-purinoceptor antagonists at two relaxation-mediating P2-purinoceptors in guinea-pig taenia coli (Naunyn Schmiedebergs). Arch Pharmacol 1996; 353: 445-51.
38. Zagorodnyuk V, Maggi CA. Pharmacological evidence for the existence of multiple P2 receptors in the circular muscle of guinea-pig colon. Br J Pharmacol 1998; 123: 122-8.
39. Boyer JL, Downes CP, Harden TK. Kinetics of activation of phospholipase C by P2Y purinergic receptor agonists and guanine nucleotides. J Biol Chem 1989; 264: 884-90.
40. Dubyak GR, el-Moatassim C. Signal transduction via P2-purinergic receptors for extracellular ATP and other nucleotides. Am J Physiol 1993; 265: C577-606 (Review).
41. Bayguinov O, Hagen B, Bonev AD, Nelson MT, Sanders KM. Intracellular calcium events activated by ATP in murine colonic myocytes. Am J Physiol Cell Physiol 2000; 279: C126-35.
42. Communi D, Paindavoine P, Place GA, Parmentier M, Boeynaems JM. Pharmacological characterization of the human P2Y11 receptor. Br J Pharmacol 1999; 128: 1199-201.
43. Qi AD, Kennedy C, Harden TK, Nicholas RA. Differential coupling of the human P2Y(11) receptor to phospholipase C and adenylyl cyclase. Br J Pharmacol 2001; 132: 318-26.
44. Pluja L, Fernandez E, Jimenez M. Neural modulation of the cyclic electrical and mechanical activity in the rat colonic circular muscle: putative role of ATP and NO. Br J Pharmacol 1999; 126: 883-92.
45. Matsuyama H, El-Mahmoudy A, Shimizu Y, Takewaki T. Nitrergic prejunctional inhibition of purinergic neuro-muscular transmission in the hamster proximal colon. J Neurophysiol 2003; 89: 2346-53.
46. Matsuda NM, Feitosa RL Jr, Lemos MC, De Oliveira RB, Ballejo G. In vitro and in vivo effects of nitric oxide synthase inhibitors and nitric oxide inactivators on the South American opossum ileocolonic junction. Neurogastroenterol Motil 1998; 10: 245-52.
47. Boeckxstaens GE, Pelckmans PA, Bult H, De Man JG, Herman AG, van Maercke YM. Evidence for nitric oxide as mediator of non-adrenergic non-cholinergic relaxations induced by ATP and GABA in the canine gut. Br J Pharmacol 1991; 102: 434-8.
48. Keef KD, Du C, Ward SM, McGregor B, Sanders KM. Enteric inhibitory neural regulation of human colonie circular muscle: role of nitric oxide. Gastroenterology 1993; 105: 1009-16.
49. Zagorodnyuk V, Maggi CA. Electrophysiological evidence for different release mechanism of ATP and NO as inhibitory NANC transmitters in guinea-pig colon. Br J Pharmacol 1994; 112: 1077-82.
50. Serio R, Mule F, Postorino A, Vetri T, Bonvissuto F. Apamin-sensitive and -insensitive components of inhibitory junction potentials in rat caecum: role of nitric oxide. J Auton Pharmacol 1996; 16: 183-9.
51. Serio R, Mule F, Postorino A. Non-adrenergic, non-cholinergic inhibitory responses to nerve stimulation in rat colonic circular muscle. Exp Physiol 1992; 77: 119-27.
52. D'Ascenzo M, Martinotti G, Azzena GB, Grassi C. cGMP/protein kinase G-dependent inhibition of N-type Ca2+ channels induced by nitric oxide in human neuroblastoma IMR32 cells. J Neurosci 2002; 22: 7485-92.
53. Yoshimura N, Seki S, de Groat WC. Nitric oxide modulates Ca(2+) channels in dorsal root ganglion neurons innervating rat urinary bladder. J Neurophysiol 2001; 86: 304-11.
54. Carabelli V, D'Ascenzo M, Carbone E, Grassi C. Nitric oxide inhibits neuroendocrine Ca(V)1 L-channel gating via cGMP-dependent protein kinase in cell-attached patches of bovine chromaffin cells. J Physiol 2002; 541: 351-66.
55. Clementi E, Sciorati C, Riccio M, Miloso M, Meldolesi J, Nistico G. Nitric oxide action on growth factor-elicited signals. Phosphoinositide hydrolysis and [Ca2+]i responses are negatively modulated via a cGMP-dependent protein kinase I pathway. J Biol Chem 1995; 270: 22277-82.
56. Harvey JS, Burgess GM. Cyclic GMP regulates activation of phosphoinositidase C by bradykinin in sensory neurons. Biochem J 1996; 316: 539-44.
57. Browning KN, Lees GM. Myenteric neurons of the rat descending colon: electrophysiological and correlated morphological properties. Neuroscience 1996; 73: 1029-47.